CEO, Xiromed, LLC
Narasimhan Mani, Ph.D., MBA, is a healthcare professional with over 21 years of experience in the pharmaceutical industry. He is currently the CEO of Xiromed LLC, which is a generics and specialty pharma company based in Florham Park, NJ. Xiromed is one of the affiliate companies of the Insud Pharma Group based in Madrid, Spain. Dr. Mani started at his current role in Feb 2019 and has had transformational success in building a robust and value added product pipeline, and built a strong US commercial organization with deep market access and relationships. One of his important goals at Xiromed is to champion affordability and accessibility to medicine.
Previously, he was the VP, Global Corporate Strategy and BD, at Amneal Pharmaceuticals, where he led all of the company's strategic initiatives across Portfolio Management, Business Development and supported the commercial organization across generics, specialty and biosimilar markets. His previous experiences include Johnson & Johnson, Par Pharmaceuticals Inc., Forest Laboratories Inc. and Elan Pharma Inc. His graduate degrees include M.S. Analytical Chemistry, from the University of Oklahoma, Ph.D. in Pharmaceutics, from the University of Georgia, and an MBA in Finance and Marketing, from Columbia Business School. He lives with his wife, son and daughter in Morris Plains. NJ.